Summary

Yumanity Therapeutics

Founded in 2014

Description

Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding.

Strengths

  • Yumanity Therapeutics has a strong market share in their industry
  • Revenue generated per employee is greater than industry average
  • Demonstrating revenue growth that is faster than the industry average
  • Since Yumanity Therapeutics was founded, the company has grown faster than the industry average

Weaknesses

  • The number of employees is not growing as fast as the industry average
  • Variance of revenue growth is more than the industry average

Annual Revenue

Yumanity Therapeutics's annual revenue

$20740000

Based on Kona Equity data

  • Revenue per employee

    $471000

  • Variance of revenue growth

    1.87

  • Annual revenue growth since founding

    $2592500

  • Revenue growth rate from first known quarter to current

    172.9%

Employee Count

44 employees

  • Employee growth rate from first known quarter to current

    15.8%

Executives

Bertrand Bourdonnec

Vice President, Medicinal Chemistry & Program Management

b**@yumanity.com

G Score - 4

The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.

  • G1 Revenue is greater than the industry median.
  • G2 Income per employee more than industry average.
  • G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
  • G6 Annual revenue growth since founding is higher than the industry average.

Location

790 Memorial Dr., Ste. 2C 
Cambridge, MA  2139

Unlock unlimited leads

Get access to millions of contacts, companies, emails, and more!

Key Information

  • Name: Yumanity Therapeutics
  • Category: Biotechnology
  • Industry: Biotechnology Company
  • SIC: 87; 873
  • NAICS: 32541; 5417
  • Disclaimer: These numbers are estimates and any other company information is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona Equity is in no way affiliated with Yumanity Therapeutics.

    See similar companies

    Next step

    Visitors review